Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lilianne R Mujica-Parodi, Ph.D.
SUNY Stony Brook University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mclean Hospital
Belmont, Massachusetts, United States
Dost Ongur, MD PhDRecruiting - Martinos Center for Biomedical Research, Building 149, 13th Street
Charlestown, Massachusetts, United States
Eva-Maria Ratai, PhDRecruiting - Laufer Center for Physical and Quantitative Biology , Stony Brook University
Stony Brook, New York, United States
Active, not recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Jan 2024
- Primary completion
- 1 Feb 2027
- Completion
- 1 Feb 2027
- Last update posted
- 15 Apr 2026
- Registered enrollment
- 100
- Registry id
- NCT06373016
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.